Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 11;15:6673–6688. doi: 10.2147/IJN.S257459

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Sun et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Antiproliferative and apoptotic effect of different PTX formulation. Cells viability of U87MG cells treated with different concentration PTX (A) or different PTX formulation; (B) was measured by CCK8 assay. *p<0.05, **p<0.01. (C) Apoptotic analysis of U87MG cells was determined using FITC/PI staining; Necrotic cells were found in the upper left quadrant, normal cells in the lower left quadrant, early apoptotic cells in the upper right quadrant, and late apoptotic cells in the lower right quadrant. (D) Hoechst stained for U87MG cells treated different PTX formulation, and the red arrow represents U87MG apoptosis bodies.

Abbreviation: PTX, paclitaxel.